TONY BRADY: Open Payments
NPI 1952024184 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,732 in 123 payments from 13 companies in 2025. Trend: 2023 $2,570 · 2024 $2,753 · 2025 $2,732
Food & beverage: $2,555Education: $177
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $665 |
| ABBVIE INC. | 28 | $614 |
| Amgen Inc. | 17 | $408 |
| E.R. Squibb & Sons, L.L.C. | 35 | $293 |
| GENZYME CORPORATION | 3 | $198 |
| UCB, Inc. | 5 | $157 |
| Novartis Pharmaceuticals Corporation | 7 | $145 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| PFIZER INC. | 3 | $50 |
| Organon LLC | 3 | $48 |
Products named: TREMFYA, RINVOQ, ORENCIA, SKYRIZI, KEVZARA, OTEZLA, KRYSTEXXA, Bimzelx.
Industry payments across MI — which companies pay providers there.
